DIN 02487144 — LIBTAYO 350 MG
LIBTAYO is a solution of Cemiplimab marketed by REGENERON CANADA COMPANY. The full Cemiplimab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02487144
- Brand name
- LIBTAYO
- Active ingredient
- Cemiplimab
- Strength
- 350 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- REGENERON CANADA COMPANY
- Health Canada status
- MARKETED
- Drug class
- PD-1 immune checkpoint inhibitor (antineoplastic monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.